X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/12/2862146/0/en/ASLAN-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/27/2853133/0/en/Aslan-Pharmaceuticals-to-Present-at-the-2nd-Annual-H-C-Wainwright-Autoimmune-and-Inflammatory-Disease-Virtual-Conference-Skin-Diseases-Conditions-and-Disorders.html
https://www.globenewswire.com//news-release/2024/03/12/2844956/0/en/ASLAN-Pharmaceuticals-Announces-5-Million-Registered-Direct-Offering.html
https://www.globenewswire.com//news-release/2024/03/11/2843626/0/en/ASLAN-Pharmaceuticals-Provides-TREK-DX-Study-Update-and-Highlights-Potential-of-Eblasakimab-in-Dupilumab-Experienced-Atopic-Dermatitis-Patients.html
https://www.globenewswire.com//news-release/2024/03/06/2841265/0/en/ASLAN-Pharmaceuticals-Announces-New-Translational-Data-on-Eblasakimab-in-COPD-and-Appoints-Leading-Respiratory-Experts-as-Scientific-Advisors.html
https://www.globenewswire.com//news-release/2024/01/08/2805232/0/en/ASLAN-Pharmaceuticals-Announces-Receipt-of-Nasdaq-Deficiency-Notice-Regarding-Minimum-Bid-Price-Requirement.html
https://www.globenewswire.com//news-release/2024/01/02/2802571/0/en/ASLAN-Pharmaceuticals-Announces-Participation-in-January-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/12/12/2794598/0/en/ASLAN-Pharmaceuticals-Provides-Year-End-Update-on-Its-Eblasakimab-and-Farudodstat-Programs.html
https://www.globenewswire.com/news-release/2023/11/20/2783117/0/en/ASLAN-Pharmaceuticals-to-Participate-in-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/03/2773084/0/en/ASLAN-Pharmaceuticals-Presents-New-Data-on-Eblasakimab-in-Atopic-Dermatitis-and-COPD-Translational-Models-at-the-7th-Dermatology-Drug-Development-Summit.html
Market Place
Share 
